Abstract
This chapter explores the biologic interactions of aging and cancer. In the process we review the epidemiology and clinical implications of cancer in the older-aged person.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Yancik R, Ries LA. Cancer in older persons: magnitude of the problem—how do we apply what we know? Cancer 1994;74:1995–2003.
Balducci L, Lyman GH. Cancer in the elderly: epidemiologic and clinical implications. Clin Geriatr Med 1997;13:1–14.
LaVecchia C, Levi F, Lucchini F, et al. International perspectives of cancer and aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:19–94.
Fernandez PM, Brem S. Malignant brain tumors in the elderly. Clin Geriatr Med 1997;13:327–338.
Stanta G, Campagner L, Cavallieri F, et al. Cancer in the oldest old: what we have learned from autopsy studies. Clin Geriatr Med 1997;13:55–68.
Extermann M, Balducci L. Practical proposals for clinical protocols in elderly patients with cancer. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, 1998:263–270.
Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol (in press); 1998;16:1582–1587.
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104–110.
Balducci L. Perspective on quality of life of older patients with cancer. Drugs Aging 1994;4:313–324.
Bennahum DA, Forman WB, Vellas B, et al. Life-expectancy, comorbidity, and quality of life: a framework of reference for medical decisions. Clin Geriatr Med 1997;13:33–53.
Bishop JM. The rise of the genetic paradigm. Genes Dev 1995;9:1309–1315.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990.
Anisimov VN. Age as a risk factor in multistage carcinogenesis. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:157–178.
Arrowsmith CH: Structure and Function in the p53. Family Cell Death Differ, 1999;6:1169–1173.
Malkin D, Jolly KV, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326:1309–1312.
Fisher DF. Apoptosis, chemotherapy and aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998: 237–246.
Minton SE, Shaw GL. Chemoprevention of cancer in the elderly. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:307–324.
Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 1997;45:482–488.
Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–2117.
Burns EA, Goodwin JS. Immunological changes of aging. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, 1998: 213–222.
Wick M, Burger G, Brusselbach S, et al. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994;269:18953–18960.
Marks R. An overview of skin cancer. Cancer 1995; 75(suppl):607–612.
Glass AG, Hoover RH. The emerging epidemic of melanoma and squamous cell cancer. JAMA 1989;262: 2097–2100.
Barbone F, Bovenzi M, Cavallieri F, et al. Air pollution and lung cancer in Trieste, Italy. Am J Epidemiol 1995;141: 1161–1169.
Erhsler WB. A gerontologist’s perspective on cancer biology and treatment. Cancer Control JMCC 1994;1:103–107.
Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994;5:29–38.
Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients. J Clin Oncol 1990;10:141–152.
Balducci L, Silliman RA, Bakae P. Breast cancer in the older woman: an oncologic perspective. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:629–660.
Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis of patients with stage I and II breast cancer. J Clin Oncol 1994;12:888–894.
Valentinis B, Silvestrini R, Daidone MG, et al. 3H thymidine labeling index, hormone receptors, and ploidy, in breast cancers from elderly patients. Breast Cancer Res Treat 1991;20:19–24.
O’Rourke MA, Feussner JR, Feigl P, et al. Age trends of lung cancer stage at diagnosis. JAMA 1987;258:921–926.
Antonia SJ, Robinson LA, Ruckdeschel JC, et al. Lung cancer. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:611–627.
Willman CL: Molecular Evaluation of Acute Myeloid Leukemia. Semin Hemetol 1999;36:390–400.
Extermann M. Acute leukemia in the elderly. Clin Geriatr Med 1997;13:227–243.
International non-Hodgkin’s lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993;329:987–994.
Thigpen JT. Gynecologic cancers. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998, 721–732.
Ershler WB. Interleukin 6: a cytokine for gerontologists. J Am Geriatr Soc 1993;41:176–181.
Butta A, Maclennan K, Flanders KC, et al. Induction of transforming growth factor beta in human breast cancer “in vivo” following tamoxifen. Cancer Res 1992;52:4261–4264.
Yee D, Sharma J, Hilsenbeck SG. Prognostic significance of insulin-like growth factor binding protein expression in axillary lymph node-negative breast cancer. J Natl Cancer Inst 1994;86:1785–1789.
Balducci L, Barry P: A practical approach to the screening of asymptomatic older persons for cancer. Cancer Control JMCC 1994:1.
Robinson B, Beghe’ C. Cancer screening in the older patient. Clin Geriatr Med 1997;13:97–118.
Olmi P, Ausili-Cefaro GP, Balzi M, et al. Radiotherapy in the aged. Clin Geriatr Med 1997;13:143–168.
Scalliet P, Pignon T. Radiotherapy in the elderly. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Hardwood Press, 1997.
Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin America 2000;14:131–168.
Balducci L, Extermann M. Cancer chemotherapy of the older patient: what the medical oncologist needs to know. Cancer (in press) 1997;80:1317–1322.
Zagonel V, Pinto A, Monfardini S. Strategies to prevent chemotherapy-related toxicities in older persons. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:481–500.
Cova D, Berretta G, Balducci L. Cancer chemotherapy in the older patient. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:429–442.
Balducci L. Medical therapy of solid tumors in the elderly: an update. Rays 1997;22:20–24.
Waller DG, Fleming JS, Ramsay B, et al. The accuracy of creatinine clearance with and withour urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991;67:42–46.
Eckardt JR, Von Hoff DD. New antineoplastic agents of interest to the older patient. In: Balducci L, Lyman GH, Ershler WB (eds) Comprehensive Geriatric Oncology. Harwood Academic Publishers, London, 1998:443–470.
Vadhan-Raj S, Murray LJ, Bueso-Ramos C, et al. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 1997:673–681.
DelMastro L, Venturini M, Lionetto R, et al. Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol 1997;15:2715–2721.
Saarto T, Blomqvist C, Enholm C, et al. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer. J Clin Oncol 1996;14:429–433.
Balducci L, Pow-Sang J, Friedland J, et al. Prostate cancer. Clin Geriatr Med 1997;13:283–306.
Balducci L, Trotti A. Organ preservation: an effective and safe form of cancer treatment. Clin Geriatr Med 1997; 13:203–219.
O’Reilly SE, Connors JM, Macpherson N, et al. Malignant lymphomas in the elderly. Clin Geriatr Med 1997; 13:251–264.
Rai K. Chronic lymphocytic leukemia in the elderly population. Clin Geriatr Med 1997;13:245–250.
Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index on ADL. JAMA 1963;185:914–919.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–1251.
Conwell Y, Forbes NT, Cox C, et al. Validation of a measure of physical illness burden at autopsy: the cumulative illness rating scale. J Am Geriatr Soc 1993;41:38–41.
Cella D. The functional assessment of cancer therapy anemia (FACT-An) scale: a new tool for the assessment of outcome in cancer anemia and fatigue. Semin Hematol 1997;34(suppl 2):13–19.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Balducci, L., Extermann, M. (2001). Cancer, Carcinogenesis, and Aging. In: Rosenthal, R.A., Zenilman, M.E., Katlic, M.R. (eds) Principles and Practice of Geriatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3432-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3432-4_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3434-8
Online ISBN: 978-1-4757-3432-4
eBook Packages: Springer Book Archive